Mid-infrared photodetectors operating over an extended wavelength range up to 90 K

We report a wavelength threshold extension, from the designed value of 3.1 to 8.9 μm, in a -type heterostructure photodetector. This is associated with the use of a graded barrier and barrier offset, and arises from hole–hole interactions in the detector absorber. Experiments show that using long-pass filters to tune the energies of incident photons gives rise to changes in the intensity of the response. This demonstrates an alternative approach to achieving tuning of the photodetector response without the need to adjust the characteristic energy that is determined by the band structure

Parsec-scale jet properties of the gamma-ray quasar 3C 286

The quasar 3C~286 is one of two compact steep spectrum sources detected by the {\it Fermi}/LAT. Here, we investigate the radio properties of the parsec(pc)-scale jet and its (possible) association with the $\gamma$-ray emission in 3C~286. The Very Long Baseline Interferometry (VLBI) images at various frequencies reveal a one-sided core--jet structure extending to the southwest at a projected distance of $\sim$1 kpc. The component at the jet base showing an inverted spectrum is identified as the core, with a mean brightness temperature of $2.8\times 10^{9}$~K. The jet bends at about 600 pc (in projection) away from the core, from a position angle of $-135^\circ$ to $-115^\circ$. Based on the available VLBI data, we inferred the proper motion speed of the inner jet as $0.013 \pm 0.011$ mas yr$^{-1}$ ($\beta_{\rm app} = 0.6 \pm 0.5$), corresponding to a jet speed of about $0.5\,c$ at an inclination angle of $48^\circ$ between the jet and the line of sight of the observer. The brightness temperature, jet speed and Lorentz factor are much lower than those of $\gamma$-ray-emitting blazars, implying that the pc-scale jet in 3C~286 is mildly relativistic. Unlike blazars in which $\gamma$-ray emission is in general thought to originate from the beamed innermost jet, the location and mechanism of $\gamma$-ray emission in 3C~286 may be different as indicated by the current radio data. Multi-band spectrum fitting may offer a complementary diagnostic clue of the $\gamma$-ray production mechanism in this source.Comment: 9 pages, 4 figures, accept for publication in MNRA

Pressure-stabilized tin selenide phase with an unexpected stoichiometry and a predicted superconducting state at low temperatures

published_or_final_versio

Study on the insecticidal activity compounds of the essential oil from Syzygium aromaticum against stored grain insect pests

Insect pests are a major cause of damage in stored grain around the world. To control the stored grain insects, synthetic insecticides have been used extensively for many years, resulting in insect populations that are resistant to insecticides. Consequently there is an interest to find alternatives to chemical pesticides. The essential oil from Syzygium aromaticum (clove oil) has a number of bioactive compounds. The chemical constituents of the clove oil were analyzed by GC-MS, and 9 of 18 compounds were identified. The main compound (83%) was 2-methoxy-4-(2-propenyl)-phenol the second most common compound (12%) was trans-caryophyllene. These two pure compounds and clove oil were tested for toxicity and repellency against Rhyzopertha dominica, Sitophilus oryzae and Tribolium castaneum. The pure compounds were tested at the dosages found in clove oil. The mortality from 2-methoxy-4-(2-propenyl)-phenol was not significantly different from clove oil, suggesting that the activity of clove oil was solely due to this major compound. The repellency results were more complex. 2-methoxy-4-(2-propenyl)-phenol was more repellant than clove oil. Trans-caryophyllene was less toxic and less repellant than both clove oil and 2-methoxy-4-(2-propenyl)- phenol. The potential for these compounds to be used to control stored product insects is discussed. Keywords: Essential oils, Syzygium aromaticum, Clove oil, Insecticidal activity compounds, Stored grain insect

Antiresistin RNA oligonucleotide ameliorates diet-induced nonalcoholic fatty liver disease in mice through attenuating proinflammatory cytokines

© 2015 Yi Tan et al. The aim of this study was to determine whether inhibition of resistin by a synthetic antiresistin RNA (oligonucleotide) oligo ameliorates metabolic and histological abnormalities in nonalcoholic fatty liver disease (NAFLD) induced by high-fat diet (HFD) in mice. The antiresistin RNA oligo and a scrambled control oligo (25 mg/kg of body weight) were i.p. injected to HFD mice. Serum metabolic parameters and hepatic enzymes were measured after 4-week treatment. The treatment significantly reduced epididymal fat and attenuated the elevated serum resistin, cholesterol, triglycerides, glucose, and insulin with an improved glucose tolerance test. Antiresistin RNA oligo also normalized serum AST and ALT levels with improved pathohistology of NAFLD. Immunoblotting and qRT-PCR revealed that decreased protein and mRNA expression of resistin in fat and liver tissues of the treated mice were associated with reduction of adipose TNF-α and IL-6 expression and secretion into circulation. mRNA and protein expression of hepatic phosphoenolpyruvate carboxykinase (PEPCK) and sterol regulatory element-binding protein-1c (SREBP-1c) were also significantly decreased in the treated mice. Our results suggest that resistin may exacerbate NAFLD in metabolic syndrome through upregulating inflammatory cytokines and hepatic PEPCK and SREBP-1c. Antiresistin RNA oligo ameliorated metabolic abnormalities and histopathology of NAFLD through attenuating proinflammatory cytokines

Comparison of chemical profiles and effectiveness between Erxian decoction and mixtures of decoctions of its individual herbs : a novel approach for identification of the standard chemicals

Acknowledgements This study was partially supported by grants from the Seed Funding Programme for Basic Research (Project Number 201211159146 and 201411159213), the University of Hong Kong. We thank Mr Keith Wong and Ms Cindy Lee for their technical assistances.Peer reviewedPublisher PD

Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms

published_or_final_versio

Expression of aquaporin 5 in primary carcinoma and lymph node metastatic carcinoma of non‑small cell lung cancer

Aquaporin 5 (AQP5), a water channel protein, is highly expressed in non‑small cell lung cancer (NSCLC) tissues compared with adjacent normal tissues. AQP5 expression in lung cancer tissues is associated with a poor prognosis. The present study aimed to analyze the expression of AQP5 and investigate its role in primary and lymph node metastatic NSCLCs. An immunohistochemical labeled streptavidin-biotin method was used to determine the expression of AQP5 in 94 cases of NSCLC primary carcinoma, which included 51 cases accompanied by lymph node metastasis. The results revealed that the expression of AQP5 was significantly higher in adenocarcinomas compared with squamous cell carcinomas (P=0.002). In addition, the percentage of AQP5 expression in the primary carcinomas with lymph node metastasis was significantly higher compared with those without lymph node metastasis (P=0.024). However, no statistically significant difference in the percentage of AQP5 expression was observed between the metastatic and the primary carcinomas (P=0.377). The expression of AQP5 exhibited a correlation with the tumor‑node‑metastasis staging of NSCLC (P=0.027). The percentage of AQP5 expression in stage III and IV tumors was higher than that in stage I and II tumors. In addition, AQP5 expression was correlated with the survival rate of NSCLC patients (P=0.051). In conclusion, the results of the present study provide evidence for the AQP5‑facilitated incidence, progression and metastasis of NSCLC.published_or_final_versio

Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma

ETHNOPHARMACOLOGICAL RELEVANCE: An oriental medicinal formulation, Huanglian Jiedu Decoction (HLJDD), has been well documented in few Traditional Chinese Medicine Classics 1300 years ago for treatment of heat and dampness-related diseases. Its effect is well accepted in Asian community, including China, Japan and Korea. Recent studies have postulated HLJDD as a regimen for cancer treatment, especially liver cancer, but the underlying mechanism is unknown. The aim of this study was to examine the suppressive effect of HLJDD on the growth of hepatocellular carcinoma (HCC) and its possible underlying mechanism. METHODS: Chemical composition of HLJDD was analyzed by high performance liquid chromatography. The tumor suppressive effect of HLJDD was determined on both HCC cells and xenograft model. Nascent protein synthesis was detected with Click-IT protein labeling technology; protein expression was determined by immunoblotting and imunnohistochemical analysis. RESULTS: Quality analysis revealed that HLJDD of different batches is consistent in both chemical composition and bioactivities. HLJDD inhibited HCC cell proliferation at its non-toxic doses, and suppressed growth and angiogenesis in xenografted murine model. HLJDD suppressed the synthesis of nascent protein via inactivation of eEF2 without deregulating the translation initiation factors. The major components in HLJDD, geniposide, berberine and baicalin, additively act on eEF2, and contributed to the responsible activity. HLJDD-activated eEF2 kinase (eEF2K) led to eEF2 inactivation, and activation of AMPK signaling may be responsible for the eEF2K induction. Blocked AMPK activity in HLJDD-treated HCC cells attenuated eEF2K activation as well as the inhibitory effect of the formula. In nutrient deprived HCC cells with inactivated eEF2, the inhibitory effect of HLJDD in tumor cell expansion was interfered. CONCLUSION: Our results indicate that HLJDD has potential in blocking HCC progression with involvement of eEF2 inhibition. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.postprin

The Role of Oxidative Stress and Antioxidants in Liver Diseases

published_or_final_versio